
浏览全部资源
扫码关注微信
广州中医药大学 临床药理研究所,广州 510405
郝徐艺,在读硕士,从事脑病的临床和实验研究,E-mail:1024515417@qq.com
陈云波,研究员,博士生导师,从事中医药防治脑病的基础研究,E-mail:ybchengz@gzucm.edu.cn
收稿日期:2018-09-04,
网络出版日期:2018-05-12,
纸质出版日期:2019-03-20
移动端阅览
郝徐艺, 罗思, 程淑意, 等. 当归芍药散对AD细胞模型铜离子介导的A
Xu-yi HAO, Si LUO, Shu-yi CHENG, et al. Effect of Danggui Shaoyaosan on Copper Ion-mediated Aβ Aggregation in AD Cell Model[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(6): 45-51.
郝徐艺, 罗思, 程淑意, 等. 当归芍药散对AD细胞模型铜离子介导的A
Xu-yi HAO, Si LUO, Shu-yi CHENG, et al. Effect of Danggui Shaoyaosan on Copper Ion-mediated Aβ Aggregation in AD Cell Model[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(6): 45-51. DOI: 10.13422/j.cnki.syfjx.20190539.
目的:
2
以
β
淀粉样蛋白1-42(A
β
1-42
)和铜离子(Cu
2+
)络合物作用的人神经母细胞瘤(SH-SY5Y)细胞为阿尔茨海默病(AD)模型,探讨Cu
2+
对A
β
聚集方式和神经毒性的影响及当归芍药散对Cu
2+
介导的A
β
毒性的AD细胞模型的影响。
方法:
2
将A
β
1-42
(20 μmol·L
-1
)与不同浓度硫酸铜(CuSO
4
,20,40 μmol·L
-1
)反应后用硫黄素T(ThT)染色法检测A
β
聚集状态,再进行A
β
1-42
-Cu
2+
组(20+20 μmol·L
-1
),当归芍药散组(1.6,3.2,6.4 mg·L
-1
)ThT染色检测A
β
聚集状态。培养SH-SY5Y细胞,分别孵育不同浓度的A
β
1-42
(1.25,2.5,5,10,20,40 μmol·L
-1
)及当归芍药散(1.6,3.2,6.4,12.8 mg·L
-1
),24 h后行噻唑蓝(MTT)比色法确定A
β
1-42
损伤浓度和当归芍药散保护浓度。随后将SH-SY5Y细胞分为空白组,A
β
1-42
-Cu
2+
组(20+20 μmol·L
-1
),当归芍药散组(20 μmol·L
-1
+20 μmol·L
-1
+1.6 mg·L
-1
),空白组加入培养基,共作用24 h后行MTT比色法检测细胞生存率,显微镜拍摄细胞形态,蛋白免疫印迹法(Western blot)检测胞内胞外A
β
1-42
聚集状况。
结果:
2
与A
β
1-42
组比较,Cu
2+
和A
β
1-42
结合成更多更大的A
β
聚集物。与正常组比较,模型组细胞活力明显降低(
P
<
0.05,
P
<
0.01),增加细胞内外A
β
1-42
聚集(
P
<
0.05,
P
<
0.01);与模型组比较,当归芍药散能提高A
β
1-42
-Cu
2+
损伤的SH-SY5Y的细胞生存率(
P
<
0.05,
P
<
0.01),减少胞外A
β
1-42
蛋白(
P
<
0.05,
P
<
0.01)。
结论:
2
Cu
2+
能够增加A
β
的聚集及毒性;当归芍药散能明显减轻Cu
2+
介导的A
β
聚集导致的SH-SY5Y细胞损伤,使A
β
内吞,减少胞外A
β
聚集,提高细胞生存率。
Objective:
2
To investigate the effect of copper ion(Cu
2+
) on the aggregation and neurotoxicity of A
β
and affirm the role of Danggui Shaoyaosan
in vitro
the Neuroblastoma (SH-SY5Y) cells treated with
β
-amyloid 1-42 (A
β
1-42
) and Cu
2+
were used as a vitro models of Alzheimer's disease(AD).
Method:
2
A
β
1-42
(20 μmol·L
-1
) was reacted with different concentrations of copper sulfate (CuSO
4
20
40 μmol·L
-1
)
and then the thioflavine T (ThT) staining method was used to detect the A
β
aggregation state. The A
β
aggregation status was also detected by ThT staining in the A
β
1-42
-Cu
2+
group(20+ 20 μmol·L
-1
)
and Danggui Shaoyaosan groups(1.6
3.2
6.4 mg·L
-1
). The SH-SY5Y cells were cultured and incubated with different concentrations of A
β
1-42
(1.25
2.5
5
10
20
40 μmol·L
-1
) and Danggui Shaoyaosan(1.6
3.2
6.4
12.8 mg·L
-1
) for 24 h. Subsequently
SH-SY5Y cells were incubated with A
β
1-42
(20 μmol·L
-1
) and CuSO
4
(20 μmol·L
-1
) in the A
β
1-42
-Cu
2+
group
and incubated with A
β
1-42
(20 μmol·L
-1
)
Danggui Shaoyaosan (1.6 mg·L
-1
) and CuSO
4
(20 μmol·L
-1
) in Danggui Shaoyaosan group. Control group was added with the medium. After 24 h of co-action
the cell viability was detected by the methylthiazolyl tetrazolium (MTT) assay. The morphology of the cells was photographed by microscopy. The intracellular extracellular A
β
1-42
aggregation was detected by Western blot.
Result:
2
Cu
2+
and A
β
1-42
bound to more and larger A
β
aggregates compared with the A
β
1-42
group. Compared with the normal group
cell viability was significantly reduced (
P
<
0.05
P
<
0.01) and intracellular and extracellular A
β
1-42
aggregation was increased(
P
<
0.05
P
<
0.01) in the model group. Danggui Shaoyaosan can increase the cell viability of SH-SY5Y damaged by A
β
-Cu
2+
(
P
<
0.05
P
<
0.01)
and reduce A
β
1-42
protein (
P
<
0.05
P
<
0.01).
Conclusion:
2
Cu
2+
can increase the aggregation and toxicity of A
β
; Danggui Shaoyaosan can significantly reduce the damage of SH-SY5Y cells induced by Cu
2+
-mediated A
β
aggregation
promote A
β
endocytosis
reduce extracellular A
β
aggregation and increase cell viability.
Akiyama H , Barger S , Barnum S , et al . Inflammation and Alzheimer's disease [J]. Neurobiol Aging , 2000 , 21 ( 3 ): 383 - 421 .
Dickson D W . Neuropathological diagnosis of Alzheimer's disease:a perspective from longitudinal clinicopathological studies [J]. Neurobiol Aging , 1997 , 18 ( 4 ): 21 - 26 .
Alvirabotero X , Carro E M. Clearance of amyloid-β peptide across the choroid plexus in Alzheimer's disease [J]. Curr Aging Sci , 2010 , 3 ( 3 ): 219 - 229 .
Lambert M P , Barlow A K , Chromy B A , et al . Diffusible,nonfibrillar ligands derived from Aβ 1-42 are potent central nervous system neurotoxins [J]. Proc Natl Acad Sci USA , 1998 , 95 ( 11 ): 6448 - 6453 .
CHEN W T , LIAO Y H , YU H M , et al . Distinct effects of Zn 2+ ,Cu 2+ ,Fe 3+ ,and Al 3+ on amyloid-beta stability,oligomerization,and aggregation:amyloid-beta destabilization promotes annular protofibril formation [J]. J Biol Chem , 2011 , 286 ( 11 ): 9646 - 9656 .
Hureau C , Faller P. Aβ-mediated ROS production by Cu ions:structural insights,mechanisms and relevance to Alzheimer's disease [J]. Biochimie , 2009 , 91 ( 10 ): 1212 - 1217 .
水岛宣昭 . トウキ·シヤクヤク散は老年痴呆にする作用 [J]. 和汉以薬学雑誌 , 1989 , 6 ( 3 ): 456 - 457 .
阎艳丽 , 吉梅 , 宋晓宇 , 等 . 当归芍药散对血脂异常大鼠抗氧化能力及动脉壁血管细胞黏附分子-1基因表达的影响 [J]. 中国实验方剂学杂志 , 2007 , 13 ( 2 ): 25 - 28 .
QIAN Y F , WANG H , YAO W B , et al . Aqueous extract of the Chinese medicine, Danggui-Shaoyao-San,inhibits apoptosis in hydrogen peroxide-induced PC12 cells by preventing cytochrome c release and inactivating of caspase cascade [J]. Cell Biol Int , 2008 , 32 ( 2 ): 304 - 311 .
HU Z Y , LIU G , CHENG X R , et al . JD-30,an active fraction extracted from Danggui-Shaoyao-San,decreases β-amyloid content and deposition,improves LTP reduction and prevents spatial cognition impairment in SAMP8 mice [J]. Exp Gerontol , 2012 , 47 ( 1 ): 14 - 22 .
KOU J , ZHU D N , YAN Y Q. Neuroprotective effects of the aqueous extract of the Chinese medicine Danggui-Shaoyao-san on aged mice [J]. J Ethnopharmacol , 2005 , 97 ( 2 ): 313 - 318 .
Arredondo M , Espinoza A , Pizarro F , et al . Searching for specific responses to copper exposure:an in vitro copper challenge in peripheral mononuclear cells [J]. Biol Trace Elem Res , 2011 , 142 ( 3 ): 407 - 414 .
SONG N , YANG H , PANG W , et al . Mulberry extracts alleviate Aβ 25-35-induced injury and change the gene expression profile in PC12 cells [J]. Evid Based Complement Alternat Med , 2014 , doi: 10.1155/2014/150617 doi:10.1155/2014/150617 .
Gaggelli E , Kozlowski H , Valensin D , et al . Copper homeostasis and neurodegenerative disorders (Alzheimer's,prion,and Parkinson's diseases and amyotrophic lateral sclerosis) [J]. Chem Rev , 2006 , 106 ( 6 ): 1995 - 2044 .
Crouch P J , Barnham K J , et al . Therapeutic treatments for Alzheimer's disease based on metal bioavailability [J]. Drug News Perspect , 2006 , 19 ( 8 ): 469 - 474 .
Desai V , Kaler S G. Role of copper in human neurological disorders [J]. Am J Clin Nutr , 2008 , 88 ( 3 ): 855 - 858 .
Bush A I , Pettingell W H , et al . Rapid induction of Alzheimer A beta amyloid formation by zinc [J]. Science , 1994 , 265 ( 5177 ): 1464 - 1467 .
Hureau C , Faller P. A beta-mediated ROS production by Cu ions:structural insights,mechanisms and relevance to Alzheimer's disease [J]. Biochimie , 2009 , 91 ( 10 ): 1212 - 1217 .
Egashira N , Iwasaki K , Akiyoshi Y , et al . Protective effect of Toki-shakuyaku-san on amyloid beta25-35-induced neuronal damage in cultured rat cortical neurons [J]. Phytother Res , 2005 , 19 ( 5 ): 450 - 453 .
钟树志 , 马世平 , 洪宗元 , 等 . 基于抗炎作用的当归芍药散抗阿尔茨海默氏症的实验研究 [J]. 中国中药杂志 , 2011 , 36 ( 22 ): 3155 - 3160 .
赵保路 , 万莉 . 金属离子代谢平衡失调与阿尔茨海默病早期发病机制 [J]. 生物化学与生物物理进展 , 2012 , 39 ( 8 ): 756 - 763 .
巩仔鹏 , 胡建春 , 李梅 , 等 . 基于大鼠脑缺血再灌注损伤模型建立辛芍组方中灯盏乙素和芍药苷的PK-PD结合模型 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 1 ): 74 - 78 .
赵冰 , 张可 , 王静 , 等 . 阿魏酸糖酯体外抗氧化性质的研究 [J]. 食品科学 , 2010 , 31 ( 21 ): 94 - 97 .
LI J , Kanekiyo T , Shinohara M , et al . Differential regulation of amyloid-beta endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms [J]. J Biol Chem , 2012 , 287 ( 53 ): 44593 - 44601 .
0
浏览量
15
下载量
8
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621